| Title: | The circadian clock protein REVERBα inhibits pulmonary fibrosis development |
| Journal: | Proceedings of the National Academy of Sciences of the United States of America |
| Published: | 26 Dec 2019 |
| Pubmed: | https://pubmed.ncbi.nlm.nih.gov/31879343/ |
| DOI: | https://doi.org/10.1073/pnas.1912109117 |
| URL: | https://www.pnas.org/content/pnas/117/2/1139.full.pdf |
| Citations: | 62 (25 in last 2 years) as of 8 Aug 2024 |
Publication 5828
WARNING: the interactive features of this website use CSS3, which your browser does not support. To use the full features of this website, please update your browser.
Abstract
Pulmonary inflammatory responses lie under circadian control; however, the importance of circadian mechanisms in the underlying fibrotic phenotype is not understood. Here, we identify a striking change to these mechanisms resulting in a gain of amplitude and lack of synchrony within pulmonary fibrotic tissue. These changes result from an infiltration of mesenchymal cells, an important cell type in the pathogenesis of pulmonary fibrosis. Mutation of the core clock protein REVERBα in these cells exacerbated the development of bleomycin-induced fibrosis, whereas mutation of REVERBα in club or myeloid cells had no effect on the bleomycin phenotype. Knockdown of REVERBα revealed regulation of the little-understood transcription factor TBPL1. Both REVERBα and TBPL1 altered integrinβ1 focal-adhesion formation, resulting in increased myofibroblast activation. The translational importance of our findings was established through analysis of 2 human cohorts. In the UK Biobank, circadian strain markers (sleep length, chronotype, and shift work) are associated with pulmonary fibrosis, making them risk factors. In a separate cohort, REVERBα expression was increased in human idiopathic pulmonary fibrosis (IPF) lung tissue. Pharmacological targeting of REVERBα inhibited myofibroblast activation in IPF fibroblasts and collagen secretion in organotypic cultures from IPF patients, thus suggesting that targeting of REVERBα could be a viable therapeutic approach.</p>
19 Keywords
- Animals
- Bleomycin
- CLOCK Proteins
- Circadian Clocks
- Fibroblasts
- Gene Expression Regulation
- Gene Knockdown Techniques
- Humans
- Idiopathic Pulmonary Fibrosis
- Integrins
- Lung
- Male
- Mesenchymal Stem Cells
- Mice
- Mice, Knockout
- Myofibroblasts
- Pulmonary Fibrosis
- TATA Box Binding Protein-Like Proteins
- Transcriptome
24 Authors
- Peter S. Cunningham
- Peter Meijer
- Alicja Nazgiewicz
- Simon G. Anderson
- Lee A. Borthwick
- James Bagnall
- Gareth B. Kitchen
- Monika Lodyga
- Nicola Begley
- Rajamiyer V. Venkateswaran
- Rajesh Shah
- Paul F. Mercer
- Hannah J. Durrington
- Neil C. Henderson
- Karen Piper-Hanley
- Andrew J. Fisher
- Rachel C. Chambers
- David A. Bechtold
- Julie E. Gibbs
- Andrew S. Loudon
- Martin K. Rutter
- Boris Hinz
- David W. Ray
- John F. Blaikley
Enabling scientific discoveries that improve human health